The Lennox Gastaut Syndrome Market is positioned for a transformative period characterized by innovative therapies and increasing demand. Forecasted to achieve a market size of USD 0.69 billion by 2024, this sector highlights a growing recognition of epilepsy treatment needs. The anticipated CAGR of 5.93% points to an increased focus on advanced treatment modalities, aiming to enhance patient...